Danh mục bài báo

ESMO Open

Công bố khoa học tiêu biểu của tạp chí. * Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp

Guidelines for the diagnosis and treatment of basal cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology

ESMO Open· Tập 8 ·Trang 102037·2023

P. Queirolo, M. Cinquini, G. Argenziano, F. Bassetto, P. Bossi, A. Boutros, C. Clemente, V. de Giorgi, M. Del Vecchio, R. Patuzzo, K. Peris, P. Quaglino, A. Reali, I. Zalaudek, F. Spagnolo

Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study

ESMO Open· Tập 7 ·Trang 100431·2022

G. Procopio, V.E. Chiuri, M. Giordano, A.R. Alitto, R. Maisano, R. Bordonaro, S. Cinieri, S. Rossetti, S. De Placido, M. Airoldi, L. Galli, D. Gasparro, G.M. Ludovico, P.F. Guglielmini, C. Carella, P. Nova, M. Aglietta, L. Schips, P. Beccaglia, A. Sciarra

Feasibility of high-throughput sequencing in clinical routine cancer care: lessons from the cancer pilot project of the France Genomic Medicine 2025 plan

ESMO Open· Tập 5 ·Trang e000744·2020

Céline Auzanneau, Delphine Bacq, Carine Bellera, Hélène Blons, Anne Boland, Marlène Boucheix, Aurélien Bourdon, Emmanuelle Chollet, Christine Chomienne, Jean-François Deleuze, Christelle Delmas, Derek Dinart, Hélène Espérou, Flore Geillon, Damien Geneste, Antoine Italiano, Delphine Jean, Emmanuel Khalifa, Yec'han Laizet, Pierre Laurent-Puig

Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials

ESMO Open· Tập 5 ·Trang e000621·2020

Jian-Guo Zhou, Lang Huang, Su-Han Jin, Cheng Xu, Benjamin Frey, Hu Ma, Udo S. Gaipl

How I treat cancer-associated thrombosis

ESMO Open· Tập 4 ·Trang e000610·2019

Florian Moik, Ingrid Pabinger, Cihan Ay

PO-101 P53 core domain activity at low PH

ESMO Open· Tập 3 ·Trang A60·2018

A.P.D. Ano Bom, C. Ano-Bom, Y. Cordeiro, J.L. Silva

Pembrolizumab versus chemotherapy for patients with esophageal squamous cell carcinoma enrolled in the randomized KEYNOTE-181 trial in Asia

ESMO Open· Tập 7 ·Trang 100341·2022

Y. Cao, S. Qin, S. Luo, Z. Li, Y. Cheng, Y. Fan, Y. Sun, X. Yin, X. Yuan, W. Li, T. Liu, C.-H. Hsu, X. Lin, S.-B. Kim, T. Kojima, J. Zhang, S.-H. Lee, Y. Bai, K. Muro, T. Doi

Bratislava Statement: consensus recommendations for improving pancreatic cancer care

ESMO Open· Tập 5 ·Trang e001051·2020

Joan Prades, Dirk Arnold, Thomas Brunner, Antonella Cardone, Alfredo Carrato, Cristina Coll-Ortega, Samuel De Luze, Pascal Garel, Maria E. Goossens, Roberto Grilli, Meggan Harris, Marleen Louagie, Núria Malats, Pamela Minicozzi, Stefano Partelli, Silvia Pastorekova, Marius Petrulionis, Richard Price, Francesco Sclafani, Bozena Smolkova

ASCO: practice changing studies in gastrointestinal cancer

ESMO Open· Tập 2 ·Trang e000228·2017

Gerald Prager

Safety and efficacy of trastuzumab biosimilar plus irinotecan or gemcitabine in patients with previously treated HER2 (ERBB2)-positive non-breast/non-gastric solid tumors: a phase II basket trial with circulating tumor DNA analysis

ESMO Open· Tập 8 ·Trang 101583·2023

J. Hyung, J.Y. Lee, J.E. Kim, S. Yoon, C. Yoo, Y.S. Hong, J.H. Jeong, T.W. Kim, S. Jeon, H.R. Jun, C.K. Jung, J.P. Jang, J. Kim, S.M. Chun, J.H. Ahn

Tổng số: 1,035